Introduction The use of hallucinogens has accompanied the human being throughout history. In 1970s, studies focused on therapeutic potential were blocked due to their misuse in young population. At present, psilocybin is re-emerging as center attention its possible different psychiatric pathologies such depression, anxiety or substance use. Objectives main objective this work been review recent...

BACKGROUND Little is known about the associations between common mental disorders and sexual dissatisfaction in the general population. AIMS To assess the associations between the presence of 12-month and remitted (lifetime minus 12-month) mood, anxiety and substance use disorders and sexual dissatisfaction in the general population of The Netherlands. METHOD A total of 6646 participants, a...

Background It remains unclear if individuals with Tourette syndrome (TS) or chronic tic disorder (CTD) have an elevated risk of subsequent substance misuse. Methods In this population-based cohort study, we investigated the association between ICD diagnoses TS/CTD and misuse outcomes, accounting for psychiatric comorbidity familial factors. The included all living in Sweden at any time January ...

background and purpose: personality disorders may lead to addiction and viral diseases. on the other hand, addiction and viral infections also cause mental and personality disorders. this research aimed at comparing personality disorders and clinical symptoms between male prisoners. materials and methods: a cross–sectional study was conducted in male prisoners in quchan, iran, 2014. three group...

BACKGROUND Ecstasy use is prevalent among young people and often co-occurs with other drug use, but little is known about the past 12-month and lifetime psychiatric comorbidity and specific additional drug abuse among young adult ecstasy users in the general population. To provide this information, we compared current ecstasy users to former users, other illicit drug users, and non-illicit drug...

Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were asso...